<html>

<head>
<meta content="text/html; charset=utf-8" />


<title>M2950303.DOC;1</title>


</head>

<body>



<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">UNITED STATES </font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">SECURITIES AND
EXCHANGE COMMISSION</font></p>

<p align=center style="margin:0in;margin-bottom:.25in;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">WASHINGTON,
D.C. 20549</font></p>

<p align=center style="margin:0in;margin-bottom:.25in;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">FORM
8-K</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">CURRENT REPORT </font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">PURSUANT TO SECTION
13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></p>

<p align=center style="margin:0in;margin-bottom:.25in;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Date
of report (Date of earliest event reported): February 27, 2012</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Medytox Solutions, Inc.</font></p>

<p align=center style="margin:0in;margin-bottom:12.0pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">(Exact
Name of Registrant as Specified in Its Charter)</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Nevada</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;margin-left:3.5in;text-align:center;text-indent:-3.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">(State or Other Jurisdiction of Incorporation)</font></p>

<p style="margin:0in;margin-bottom:.0001pt;text-align:justify;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<div align=center>

<table border=0 cellpadding=0 cellspacing=0 style="margin-left:0pt;width:0px;">
 <tr>
  <td valign=top width=48% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">000-54346</font></p>
  </td>
 <td valign=top width=52% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">54-2156042</font></p>
  </td>
 </tr>
<tr>
  <td valign=top width=48% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Commission File
  Number)</font></p>
  </td>
 <td valign=top width=52% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(I.R.S. Employer
  Identification No.)</font></p>
  </td>
 </tr>
</table>

</div>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<div align=center>

<table border=0 cellpadding=0 cellspacing=0 style="width:0px;">
 <tr>
  <td valign=top width=77% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">400 S. Australian
  Avenue, Suite 800, West Palm Beach, Florida</font></p>
  </td>
 <td valign=top width=23% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">33401</font></p>
  </td>
 </tr>
<tr>
  <td valign=top width=77% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Address of
  Principal Executive Offices)</font></p>
  </td>
 <td valign=top width=23% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Zip Code)</font></p>
  </td>
 </tr>
</table>

</div>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=center style="margin:0in;margin-bottom:12.0pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">(561)
855-1626<br>
(Registrant&#8217;s Telephone Number, Including Area Code)</font></p>

<p align=center style="margin:0in;margin-bottom:12.0pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">(Former
Name or Former Address, if Changed Since Last Report)</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face=Wingdings lang=EN-US style="font-size:12.0pt;">o</font><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;"> Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face=Wingdings lang=EN-US style="font-size:12.0pt;">o</font><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;"> Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face=Wingdings lang=EN-US style="font-size:12.0pt;">o</font><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;"> Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face=Wingdings lang=EN-US style="font-size:12.0pt;">o</font><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;"> Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">_______________________________________________</font></p>




<p style="margin:0in;margin-bottom:.0001pt;text-align:justify;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Section 5 &#8211; Corporate
Governance and Management</font></b></p>

<p style="margin:0in;margin-bottom:.0001pt;text-align:justify;text-indent:.5in;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Item 5.02.&#160; Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers</font></b></p>

<p style="margin:0in;margin-bottom:.0001pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">On February 27, 2012, Medytox
Solutions, Inc. (&quot;Medytox&quot;) appointed Jace Simmons the Chief
Financial Officer of Medytox effective March 1, 2012, and entered into an
Employment Agreement (the &quot;Agreement&quot;) with Mr. Simmons to employ him
as Chief Financial Officer of Medytox.&#160; The term of the Agreement is for two
years, renewable for additional one-year periods if neither party otherwise
gives at least 90 days notice.&#160; Under the Agreement, Mr. Simmons will receive
an annual salary of $150,000, subject to review each year.&#160; He will participate
in senior management bonus programs to be approved by the Board of Directors.&#160;
He will also receive annually options to purchase 200,000 shares of Medytox
common stock exercisable at $3.00 a share.&#160; When the common stock commences
trading, Mr. Simmons will receive options to purchase an additional 400,000
shares, also exercisable at $3.00 a share.&#160; Medytox will also reimburse Mr.
Simmons for agreed-upon moving expenses and for his temporary housing expenses
for up to 90 days.</font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">In the event
Medytox is merged or acquired by another company and Mr Simmons' position
changes, he will be offered an amount equal to his compensation and benefits to
the end of the then current term.&#160; If Mr. Simmons dies during the term of the
Agreement, his estate will be paid his compensation for the lesser of one year
and the end of the then current term.&#160; If the Agreement is terminated due to
disability, Mr. Simmons will receive his compensation for four weeks after
termination. </font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Mr. Simmons is
55 years old and has been the Chief Financial Officer of Renaissance PG, LLC, a
real estate developer and manager in Knoxville, Tennessee, since June 2007.&#160;
Prior to that, from 2005, he was Chief Financial Officer of Housing Trust
Group,</font><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;"> </font></b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">a real estate developer and manager in Miami, Florida.&#160; Mr.
Simmons also served as Chief Financial Officer of Paving Stone Corp., an OTC
Bulletin Board company, from 2000 to 2004.&#160; There are no family relationships
between Mr. Simmons and any of Medytox's directors and executive officers and
Medytox has not entered into any transactions with Mr. Simmons that would
require disclosure under Item 404(a) of Regulation S-K.</font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">The foregoing
is qualified by reference to the Agreement, a copy of which is filed herewith
as Exhibit 10.1.</font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Section 9 &#8211; Financial
Statement and Exhibits</font></b></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Item 9.01.
Financial Statements and Exhibits</font></b></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">2</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">_______________________________________________</font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p style="margin:0in;margin-bottom:12.0pt;page-break-after:avoid;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">(d)&#160; Exhibits</font></p>

<div align=left><table border=0 cellpadding=0 cellspacing=0 style="border-collapse:collapse;width:0px;">
 <tr style="height:22.05pt;page-break-inside:avoid;">
  <td valign=top width=50% style="height:22.05pt;padding:0in 5.4pt 0in 5.4pt;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;page-break-after:avoid;text-align:center;"><u><font face="Times New Roman,serif" style="font-size:12.0pt;">Exhibit Number</font></u></p>
  </td>
 <td valign=top width=50% style="height:22.05pt;padding:0in 5.4pt 0in 5.4pt;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><u><font face="Times New Roman,serif" style="font-size:12.0pt;">Description</font></u></p>
  </td>
 </tr>
<tr style="height:58.5pt;page-break-inside:avoid;">
  <td valign=top width=50% style="height:58.5pt;padding:0in 5.4pt 0in 5.4pt;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">10.1</font></p>
  </td>
 <td valign=top width=50% style="height:58.5pt;padding:0in 5.4pt 0in 5.4pt;">
  <p style="margin:0in;margin-bottom:.0001pt;text-align:justify;"><font face="Times New Roman,serif" style="font-size:12.0pt;">Employment Agreement, effective March 1, 2012, between
  Medytox Solutions, Inc. and Jace Simmons. </font></p>
  </td>
 </tr>
</table></div>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;page-break-after:avoid;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;page-break-after:avoid;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">3</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">_______________________________________________</font></p>




<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;page-break-after:avoid;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">SIGNATURES</font></b></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized. </font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Date: February 28, 2012&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; MEDYTOX
SOLUTIONS, INC.</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">/s/
William G. Forhan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></u></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; William
G. Forhan,</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; CEO,
CFO and Chairman</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (principal
executive officer)</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">4</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">_______________________________________________</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>








<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">EXHIBIT INDEX</font></b></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:justify;"><u><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Exhibit No.</font></u><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Description&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></u></p>

<p style="margin-bottom:12.0pt;margin-left:1.5in;margin-right:0in;margin-top:0in;text-align:justify;text-indent:-1.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">10.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Employment
Agreement, effective March 1, 2012, between Medytox Solutions, Inc. and Jace
Simmons. </font></p>

<p style="margin-bottom:12.0pt;margin-left:1.5in;margin-right:0in;margin-top:0in;text-align:justify;text-indent:-1.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">5</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">_______________________________________________</font></p>






</body>

</html>
[{"type": "8-K", "sequence": "1", "filename": "msi8k022812.htm", "secsgml_size_bytes": 23009}]
{"company-data": {"conformed-name": "Medytox Solutions, Inc.", "cik": "0001374536", "assigned-sic": "8734", "irs-number": "542156042", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54346", "film-number": "12647408"}, "business-address": {"street1": "400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR", "city": "WEST PALM BEACH", "state": "FL", "zip": "33401", "phone": "(561) 855-1626"}, "mail-address": {"street1": "400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR", "city": "WEST PALM BEACH", "state": "FL", "zip": "33401"}, "former-company": {"former-conformed-name": "CASINO PLAYERS, INC.", "date-changed": "20060905"}}
M2950303.DOC;1
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION
13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): February 27, 2012
Medytox Solutions, Inc.
(Exact
Name of Registrant as Specified in Its Charter)
Nevada
(State or Other Jurisdiction of Incorporation)
000-54346
54-2156042
(Commission File
  Number)
(I.R.S. Employer
  Identification No.)
400 S. Australian
  Avenue, Suite 800, West Palm Beach, Florida
33401
(Address of
  Principal Executive Offices)
(Zip Code)
(561)
855-1626
(Registrant's Telephone Number, Including Area Code)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
_______________________________________________
Section 5 – Corporate
Governance and Management
Item 5.02.  Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers
On February 27, 2012, Medytox
Solutions, Inc. ("Medytox") appointed Jace Simmons the Chief
Financial Officer of Medytox effective March 1, 2012, and entered into an
Employment Agreement (the "Agreement") with Mr. Simmons to employ him
as Chief Financial Officer of Medytox.  The term of the Agreement is for two
years, renewable for additional one-year periods if neither party otherwise
gives at least 90 days notice.  Under the Agreement, Mr. Simmons will receive
an annual salary of $150,000, subject to review each year.  He will participate
in senior management bonus programs to be approved by the Board of Directors. 
He will also receive annually options to purchase 200,000 shares of Medytox
common stock exercisable at $3.00 a share.  When the common stock commences
trading, Mr. Simmons will receive options to purchase an additional 400,000
shares, also exercisable at $3.00 a share.  Medytox will also reimburse Mr.
Simmons for agreed-upon moving expenses and for his temporary housing expenses
for up to 90 days.
In the event
Medytox is merged or acquired by another company and Mr Simmons' position
changes, he will be offered an amount equal to his compensation and benefits to
the end of the then current term.  If Mr. Simmons dies during the term of the
Agreement, his estate will be paid his compensation for the lesser of one year
and the end of the then current term.  If the Agreement is terminated due to
disability, Mr. Simmons will receive his compensation for four weeks after
termination.
Mr. Simmons is
55 years old and has been the Chief Financial Officer of Renaissance PG, LLC, a
real estate developer and manager in Knoxville, Tennessee, since June 2007. 
Prior to that, from 2005, he was Chief Financial Officer of Housing Trust
Group,
a real estate developer and manager in Miami, Florida.  Mr.
Simmons also served as Chief Financial Officer of Paving Stone Corp., an OTC
Bulletin Board company, from 2000 to 2004.  There are no family relationships
between Mr. Simmons and any of Medytox's directors and executive officers and
Medytox has not entered into any transactions with Mr. Simmons that would
require disclosure under Item 404(a) of Regulation S-K.
The foregoing
is qualified by reference to the Agreement, a copy of which is filed herewith
as Exhibit 10.1.
Section 9 – Financial
Statement and Exhibits
Item 9.01.
Financial Statements and Exhibits
2
_______________________________________________
(d)  Exhibits
Exhibit Number
Description
10.1
Employment Agreement, effective March 1, 2012, between
  Medytox Solutions, Inc. and Jace Simmons.
3
_______________________________________________
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 28, 2012                                             MEDYTOX
SOLUTIONS, INC.
/s/
William G. Forhan
William
G. Forhan,
CEO,
CFO and Chairman
(principal
executive officer)
4
_______________________________________________
EXHIBIT INDEX
Exhibit No.
Description
10.1                             Employment
Agreement, effective March 1, 2012, between Medytox Solutions, Inc. and Jace
Simmons.
5
_______________________________________________